Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,541,949 papers from all fields of science
Search
Sign In
Create Free Account
S100A14 gene
Known as:
S100A14
, S100A15
, S100 calcium binding protein A14
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Extracell Newly Ident RAGE Bind Protein measurement
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma
Yung-Che Chen
,
Meng-Chih Lin
,
+9 authors
Jen‐Chieh Chang
OncoTarget
2017
Corpus ID: 917047
Purpose This study aims to determine the functional role of S100A15 and its promoter DNA methylation patterns in lung cancer…
Expand
2017
2017
S100A14 rs11548103 G>A polymorphism is associated with a decreased risk of esophageal cancer in a Chinese population
Yang Zhao
,
F. Yao
,
Weifeng Tang
,
H. Gu
,
Heng Zhao
OncoTarget
2017
Corpus ID: 21679353
Objective In China in 2009, esophageal cancer was the fifth most commonly diagnosed malignancy and the fourth leading cause of…
Expand
2016
2016
[Expression and regulatory mechanism of S100A14 in breast cancer].
C. S. Xu
,
H. Chen
,
C. Lu
,
Z. H. Liu
Zhonghua zhong liu za zhi [Chinese journal of…
2016
Corpus ID: 28744197
OBJECTIVE To explore the expression of S100A14 in breast cancer tissue, and the EGF and S100A14 feedback regulatory mechanism…
Expand
2016
2016
SOX2 suppresses the mobility of urothelial carcinoma by promoting the expression of S100A14
Moon-Sing Lee
,
Wan-Ting Hsu
,
+5 authors
Chin Li
Biochemistry and Biophysics Reports
2016
Corpus ID: 12408842
2016
2016
Correction: S100A14 Stimulates Cell Proliferation and Induces Cell Apoptosis at Different Concentrations via Receptor for Advanced Glycation End Products (RAGE)
Qing'e Jin
,
Hongyan Chen
,
A. Luo
,
F. Ding
,
Zhihua Liu
PLoS ONE
2016
Corpus ID: 54569266
Western blot was performed to detect S100A14 in the culture media from EC9706 cells stably transfected with HA-tag S100A14 full…
Expand
2013
2013
Differential proteomic analysis of cancer stem cell properties in hepatocellular carcinomas by isobaric tag labeling and mass spectrometry.
C. Ko
,
Chieh-Fang Cheng
,
+10 authors
Sung‐Fang Chen
Journal of Proteome Research
2013
Corpus ID: 10973216
Malignant tumors are relatively resistant to treatment due to their heterogeneous nature, drug resistance, and tendency for…
Expand
2013
2013
S 100 A 14 Promotes the Growth and Metastasis of Hepatocellular Carcinoma
Fu-tao Zhao
,
Z. Jia
,
Qun Yang
,
Le Song
,
X. Jiang
2013
Corpus ID: 21695361
Hepatocellular carcinoma (HCC) is the one of the most common and aggressive cancers worldwide (Pu et al., 2013). The primary…
Expand
2012
2012
Loss of S100A14 Expression Is Associated with the Progression of Adenocarcinomas of the Small Intestine
Gwangil Kim
,
J. Chung
,
+6 authors
Seung‐Mo Hong
Pathobiology (Basel)
2012
Corpus ID: 13047615
Objectives: Small intestinal adenocarcinoma (SIAC) is an exceedingly rare human malignant tumor, and its association with the…
Expand
2006
2006
Gene expression profiling of clinical stages II and III breast cancer.
M. A. Folgueira
,
H. Brentani
,
+14 authors
M. Brentani
Brazilian journal of medical and biological…
2006
Corpus ID: 24651520
Clinical stage (CS) is an established indicator of breast cancer outcome. In the present study, a cDNA microarray platform…
Expand
2006
2006
Purification, crystallization and preliminary X-ray diffraction of human S100A15.
Karen M. Boeshans
,
R. Wolf
,
+5 authors
B. Ahvazi
Acta Crystallographica. Section F : Structural…
2006
Corpus ID: 25216022
Human S100A15 is a novel member of the S100 family of EF-hand calcium-binding proteins and was recently identified in psoriasis…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE